Jiangsu Aidea Pharmaceutical Group Co., Ltd. Class ASSE: 688488

"JIANGSU AIDEA PHARMACEUTICAL GROUP CO., LTD."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry

Sep 8, 2026 · Issued by Jiangsu Aidea Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Jiangsu Aidea Pharmaceutical Group Co., Ltd. Class A

"JIANGSU AIDEA PHARMACEUTICAL GROUP CO., LTD."Announcement on Failure to Satisfy Exercise Conditions for the 1st Exercise Period under the 2025 Stock Option Incentive Plan and Cancellation of Certain Stock OptionsAug 29
"JIANGSU AIDEA PHARMACEUTICAL GROUP CO., LTD."Announcement on Pledge of Certain Shares Held by Persons Acting in Concert with the Actual ControllerAug 19
"JIANGSU AIDEA PHARMACEUTICAL GROUP CO., LTD."Announcement on Results of Shareholding Increase by the Actual ControllerAug 14
"JIANGSU AIDEA PHARMACEUTICAL GROUP CO., LTD."Announcement on Progress of Acquisition of the Minority Shareholder's Equity Interests in Controlled SubsidiaryAug 13

All Jiangsu Aidea Pharmaceutical Group Co., Ltd. Class A news releases